Immunotherapy Continues Growth With Trials in mCRPC – OncLive
OncLive |
Immunotherapy Continues Growth With Trials in mCRPC
OncLive OncLive: Can you discuss your lecture on immunotherapy in prostate cancer? Graff: I spoke about the status of immunotherapy in prostate cancer, which is a very interesting topic that is evolving. We have 1 approved immunotherapeutic agent called … |
